Lamassu Biotech

Lamassu Biotech, a cutting-edge biotechnology company dedicated to innovative cancer therapies, has received funding from the National Institutes of Health (NIH) and the National Cancer Institute (NCI) for the development of a breakthrough treatment targeting p53 wild-type sarcoma.